Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells

por Marzec, Michal, Liu, Xiaobin, Wysocka, Maria, Rook, Alain H., Odum, Niels, Wasik, Mariusz A.
Publicado 2011

TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones

por Shaw, Lauren C., Poussin, Mathilde, Rodriguez-Garcia, Alba, Eggold, Joshua, Minutolo, Nicholas G., Wang, Jie, Rook, Alain H., Schuster, Stephen J., Powell, Daniel J.
Publicado 2022

Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis Fungoides

por DEL GUZZO, Christina A., JARIWALA, Neha N., HAUN, Paul L., MACARTHUR, Kelly M., MOWAD, Christen M., RICHARD, Elisabeth G., HOLTON, Joseph P., ROOK, Alain H.
Publicado 2020

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas

por Paralkar, Vikram R., Nasta, Sunita Dwivedy, Morrissey, Kelly, Smith, Jacqueline, Vassilev, Pavel, Martin, Mary Ellen, Goldstein, Steven C, Loren, Alison, Rook, Alain H., Kim, Ellen J, Porter, David L
Publicado 2011

CD164 and FCRL3 are highly expressed on CD4+CD26-T cells in Sézary syndrome patients

por Wysocka, Maria, Kossenkov, Andrew V., Benoit, Bernice M., Troxel, Andrea B., Singer, Elisha, Schaffer, Andras, Kim, Brian, Dentchev, Tzvete, Nagata, Satoshi, Ise, Tomoko, Showe, Louise C., Rook, Alain H.
Publicado 2013

Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma

por Kim, Ellen J., Kim, Youn H., Rook, Alain H., Lerner, Adam, Duvic, Madeleine, Reddy, Sunil, Robak, Tadeusz, Becker, Jürgen C., Samtsov, Alexey, McCulloch, William, Waksman, Joel, Whittaker, Sean
Publicado 2015

Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma

por Kari, Laszlo, Loboda, Andrey, Nebozhyn, Michael, Rook, Alain H., Vonderheid, Eric C., Nichols, Calen, Virok, Dezso, Chang, Celia, Horng, Wen-Hwai, Johnston, James, Wysocka, Maria, Showe, Michael K., Showe, Louise C.
Publicado 2003

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

por Watanabe, Keisuke, Gomez, Angela M., Kuramitsu, Shunichiro, Siurala, Mikko, Da, Tong, Agarwal, Sangya, Song, Decheng, Scholler, John, Rotolo, Antonia, Posey, Avery D., Rook, Alain H., Haun, Paul L., Ruella, Marco, Young, Regina M., June, Carl H.
Publicado 2023

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

por Siu, Lillian, Brody, Joshua, Gupta, Shilpa, Marabelle, Aurélien, Jimeno, Antonio, Munster, Pamela, Grilley-Olson, Juneko, Rook, Alain H, Hollebecque, Antoine, Wong, Rebecca K S, Welsh, James W, Wu, Yuling, Morehouse, Christopher, Hamid, Oday, Walcott, Farzana, Cooper, Zachary A, Kumar, Rakesh, Ferté, Charles, Hong, David S
Publicado 2020

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

por Musiek, Amy C. M., Rieger, Kerri E., Bagot, Martine, Choi, Jennifer N., Fisher, David C., Guitart, Joan, Haun, Paul L., Horwitz, Steven M., Huen, Auris Onn-Lay, Kwong, Bernice Y., Lacouture, Mario E., Noor, Sarah J., Rook, Alain H., Seminario-Vidal, Lucia, Vermeer, Maarten H., Kim, Youn H.
Publicado 2021

Primary Cutaneous Aggressive Epidermotropic Cytotoxic T-cell Lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

por Guitart, Joan, Martinez-Escala, M. Estela, Subtil, Antonio, Duvic, Madeleine, Pulitzer, Melissa P., Olsen, Elise A., Kim, Ellen, Rook, Alain H, Samimi, Sara S., Wood, Gary S., Girardi, Michael, Junkins-Hopkins, Jacqueline, Ivan, Doina S., Selim, M. Angelica, Sable, Kimberly A., Virmani, Pooja, Pincus, Laura B., Tetzlaff, Michael T., Kim, Jinah, Kim, Youn H.
Publicado 2017